Horizon Pharma (HZNP) Posts Q2 Loss of 62c/Share, Narrower than Views

Horizon Pharma (NASDAQ: HZNP) reported Q2 EPS of ($0.62), $0.04 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $4.44 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Innovaro (INV) Misses Q2 EPS by 9c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c